NKMAX 的蛋白质和抗体开发源于其稳定肽 (SP) 融合技术,该技术最初旨在稳定易受环境损害的蛋白质。
NKMAX 生产超过 5,000 种不同的重组蛋白和超过 400 种单克隆抗体,在全球超过 38 个国家销售。
nkmaxbio2021年9月新增蛋白产品:
Product Name | Catalog# | Size | Size | Size | |
Signal Transduction, Cytoskeleton | Recombinant human COMP protein | ATGP4037 | 500ug | 100ug | 50ug |
Angiogenesis, Cardiovascular | Recombinant human EphB1 protein | ATGP4038 | 500ug | 100ug | 50ug |
Immunology | Recombinant human IL-17RB protein | ATGP4039 | 500ug | 100ug | 50ug |
Angiogenesis, Cardiovascular, Adhesion & Movement | Recombinant mouse TIMP-1 protein | ATGP4040 | 500ug | 100ug | 50ug |
Cell Cycle | Recombinant human MKK6 protein | ATGP4041 | 500ug | 100ug | 50ug |
Immunology | Recombinant human LILRB2/CD85d/ILT4 protein | ATGP4042 | 500ug | 100ug | 50ug |
电话
QQ咨询
4006551678